Clementia pharmaceuticals inc. (CMTA)
CashFlow / TTM
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Classes of share capital [axis]
Share capital [member]
Series C preferred shares [member]
Operating activities
Net loss

-50,564

-74,793

-87,349

-115,455

0

0

0

Adjusting items
Interest income recognized in net loss

2,200

1,984

1,552

1,082

0

0

0

Depreciation of property and equipment

19

20

22

25

0

0

0

Amortization of intangible assets

193

193

193

179

0

0

0

Transaction costs recognized in net loss

0

0

0

35

0

0

0

Embedded derivative loss recognized in net loss

-

-

-42,585

-77,902

0

0

0

Accretion preferred shares

0

393

1,491

2,479

0

0

0

Share-based compensation

4,362

3,502

2,828

2,180

0

0

0

Net foreign exchange gain

44

29

-16

-40

0

0

0

Income tax expense recognized in net loss

1,111

688

640

643

0

0

0

Income taxes paid

326

364

352

392

0

0

0

Tax credits

0

0

0

-

-

-

0

Net changes in working capital
Sales tax and other receivables

-2

-48

56

-3

0

0

0

Investment tax credits receivable

859

835

828

761

0

0

0

Deferred financing costs

0

-

0

-

0

0

0

Prepaid expenses

864

5,175

1,709

3,146

0

0

0

Accounts payable and accrued liabilities

2,435

2,562

5,004

2,193

0

0

0

Net operating cash flows

-47,402

-46,922

-39,371

-35,566

0

0

0

Investing activities
Interest income received

2,278

710

648

814

0

0

0

Acquisition of short and long-term investments

20,000

114,000

119,000

134,000

0

0

0

Maturity of short-term investments

40,000

34,000

34,000

59,000

0

0

0

Acquisition of property and equipment

-

-

12

20

0

0

0

Acquisition of intellectual property

-

-

-

-

-

0

-

Net investing cash flows

22,275

-79,297

-85,363

-75,206

0

0

0

Financing activities
Issuance of common shares

-

-

5

31

0

0

0

Proceeds from initial public offering

-

-

-

-

0

-

-

Share issuance costs

-

-

-

-

0

-

-

Net financing cash flows

-

-

127,634

137,530

0

0

0

Net (decrease) increase in cash

-25,126

1,409

2,899

26,757

0

0

0

Effect of exchange rate fluctuations on cash held

-54

-56

17

37

0

0

0